Salveen Richter

Stock Analyst at Goldman Sachs

(0)
# 4786
Out of 5,370 analysts
220
Total ratings
33.33%
Success rate
-18.25%
Average return
54 Stocks
Name Action PT Current % Upside Ratings Updated
ELVN Enliven Therapeutics
Initiates Coverage On: Buy
37
23.07 60.38% 1 Jun 16, 2025
FDMT 4D Molecular Therape...
Maintains: Buy
51 44
4.38 904.57% 4 May 9, 2025
CRSP CRISPR Therapeutics
Maintains: Neutral
53 47
41.66 12.82% 4 May 8, 2025
RCUS Arcus Biosciences
Maintains: Neutral
15 13
9.08 43.17% 3 May 8, 2025
SRPT Sarepta Therapeutics
Maintains: Buy
178 100
20.99 376.42% 4 May 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
124 104
56.19 85.09% 1 May 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
37 41
19.97 105.31% 2 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
12 9
6.05 48.76% 2 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
9 10
10.26 -2.53% 10 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
917 804
522.29 53.94% 5 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
219 197
131.07 50.3% 4 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
36 32
18.32 74.67% 8 Mar 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 18
3.29 447.11% 3 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
85 96
110.72 -13.29% 4 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
99 51
26 96.15% 10 Jan 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 40
14.59 174.16% 5 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
20 12
8.96 33.93% 8 Jan 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
9 20
15.11 32.36% 7 Dec 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
63 70
71.13 -1.59% 6 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
198 370
308.78 19.83% 5 Aug 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
67 76
37.03 105.24% 3 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
33 37
35.28 4.88% 3 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
19 11
9.06 21.41% 9 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
33 53
35.5 49.3% 8 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
313 350
295.12 18.6% 4 Feb 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
442 559
450.66 24.04% 4 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
5
n/a n/a 4 Sep 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
5 5
12.6 -60.32% 5 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 31
1.36 2179.41% 7 Mar 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
257 225
298.97 -24.74% 1 Feb 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
22
1.5 1366.67% 1 Nov 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Nov 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
60 30
5.08 490.55% 5 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
25 14
0.89 1473.03% 3 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
8 9
5.03 78.93% 6 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
16 3
2.54 18.11% 4 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
15 12
22.12 -45.75% 8 Nov 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 6
2.52 138.1% 3 Nov 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
39 43
52.47 -18.05% 1 Oct 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
40 60
n/a n/a 6 Aug 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
216 188
n/a n/a 3 Jun 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
125 100
8.55 1069.59% 1 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
7 4
n/a n/a 2 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
3 2
1.38 44.93% 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
39 34
n/a n/a 3 Mar 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
28 5
n/a n/a 2 Jan 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
17 10
n/a n/a 5 Aug 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
28 30
n/a n/a 3 Mar 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
57 50
92.62 -46.02% 3 Mar 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
45
15.66 187.36% 1 Mar 17, 2020